The FDA has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.

We are dreaming too small, to the neglect of all our students and our city,” writes Russell Askren in an op-ed. “We need to ...

Artificial intelligence (AI) continues to shape your daily life, from online shopping to medical research. Yet behind every ...

When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...

Learn more about whether Alvotech or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Q4 2024 Earnings Call Transcript March 31, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.54, ...

Learn more about whether Ionis Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Central Michigan University is opening new pathways into one of Michigan’s most exciting industries – casino and resort ...

Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...

There are many misconceptions about youth apprenticeships, but they're powerful pathway to career success. In this article, a current youth apprentice dispels myths about this earn-and-learn model.